Stone Christopher Lewis 4/A
4/A · PDL BIOPHARMA, INC. · Filed Apr 7, 2020
Insider Transaction Report
Form 4/AAmended
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common stock
2020-01-08+422,078→ 617,103 total
Footnotes (1)
- [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control.